EVERSION Technologies Raises €2.3 Mn Seed II to Expand MedTech Innovation

The funding round was led by Kammerer Holding and the Kreissparkasse Biberach Opportunity Capital Fund. The fund had also led EVERSION's Seed I funding round at the beginning of 2025.

The new investment will help EVERSION expand its sales and marketing teams, grow its partner network, and speed up the adoption of its medical technology solution.

“I know from my own experience how hip pain can take over daily life. It means so much to me that we can help so many people with our solution,” says Zimmermann, co-founder and CEO of EVERSION.

Christopher Kammerer of Kammerer Holding adds: “As a family office, we invest for the long term and with conviction. EVERSION combines what matters most to us: a real solution to a widespread problem, a strong team, and a viable, innovative business model.”

Founded in 2022 by Julia Zimmermann, Timon Sutter, Lucas Heitele, and Maximilian Starkmann, EVERSION Technologies is a MedTech startup based in Konstanz, Germany. The company develops medical technology to help doctors and healthcare professionals provide better care to patients.

Its main goal is to create digital healthcare solutions that make medical services more efficient and improve patient treatment.

EVERSION also works with hospitals, clinics, and healthcare partners to bring its technology to more people and expand the use of its medical solutions.

Read Also- Ahead Health Raises €8.7 Mn to Expand AI-Powered Preventive Healthcare Across Europe